BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Brivanib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Brivanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cediranib
36 shared targets
motesanib
24 shared targets
raf
28 shared targets
lenvatinib
17 shared targets
osi
21 shared targets
vandetanib
36 shared targets
quizartinib
25 shared targets
doramapimod
29 shared targets
cabozantinib
16 shared targets
tandutinib
17 shared targets
Loading evidence profile...

This evidence profile for Brivanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.